Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Not all wealth building strategies are created equal. Discover the ones that truly work and can help you grow your finances effectively.
17,941 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
When a single stock surges on earnings guidance, it signals more than a momentary spike. This guide explains why band...
Booking Holdings trades at elevated levels, reigniting debate over whether a stock split could broaden retail ownersh...
President Trump signals possible limited military action against Iran as nuclear talks proceed, a move that could res...
Ethereum faces a pivotal juncture as it tests critical support while the longer-term trend remains bearish. Traders w...
Standard Chartered projects stablecoins could generate up to $1 trillion of new US Treasury demand by 2028, signaling...
A new wave of tariff talk harkens back to a controversial era. This piece explains why trump’s tariffs: lesson econom...
A new AI-driven marketing platform is raising Reg A+ funds at $0.85 per share, pitching a fast-growth TMT play for in...
A dramatic surge in a single year can turn heads, but investors need more than headlines. This article dives into whe...
The Trade Desk prepares to report quarterly results as investors grapple with a steep stock drop, focusing on revenue...
This in-depth guide analyzes agilon health (agl) 2025 implications for investors. Learn the business model, key metri...
A new ElevenLabs case study shows better.com’s Betsy AI voice agent slashing origination costs by 41% in 2025 while l...